The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The India Pharmaceutical Packaging market is expected to exhibit a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Pharmaceutical packaging aids in the storage, protection, traceability, and identification of different pharmaceutical products. It involves primary packaging that safeguards medicinal products from environmental, chemical, mechanical and other hazards. It also includes secondary packaging that provides information about different drugs and tertiary packaging, which prevents damage to products and assists in bulk handling and shipping. Some of the commonly used pharmaceutical packaging in India are ampoules, bottles, vials, blister packs, and sachet packaging.
The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular and respiratory diseases, represents one of the key factors bolstering the growth of the market in India. Moreover, the Government of India has introduced the Production Linked Incentive (PLI) scheme for encouraging domestic manufacturing of critical key starting materials (KSMs)/ drug intermediates (DIs) and active pharmaceutical ingredients (APIs) to reduce import dependence. It is also establishing health and wellness centres (HWCs) to deliver comprehensive primary health care (CPHC) that cover non-communicable diseases and maternal and child health services, comprising free essential drugs and diagnostic services. This, along with the rising sales of numerous medicines and nutritional supplements on account of the coronavirus disease (COVID-19) outbreak, is catalyzing the demand for pharmaceutical packaging across India. Furthermore, increasing exports of generic medicines and other pharmaceutical products, coupled with the rising adoption of new regulatory standards for packaging recycling, is positively influencing the market. Apart from this, the development of child-resistant packaging (CRP), which can minimize the risk of poisoning among children through the ingestion of prescription drugs and over the counter (OTC) medicines, is projected to stimulate the market growth in India.
IMARC Group provides an analysis of the key trends in each sub-segment of the India pharmaceutical packaging market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on material type, product type and end user.
Breakup by Material Type:
Breakup by Product Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2021|
|Segment Coverage||Material Type, Product Type, End User, Region|
|Region Covered||North India, West and Central India, South India, East India|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at